Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model.

@article{Griffin2001PreclinicalEO,
  title={Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model.},
  author={Gregory M Griffin and Tongyu Zhu and Michael Solonenko and Fabio del Piero and A Kapakin and Theresa M. Busch and A. G. Yodh and Glenn M. Polin and Timm Bauer and Douglas Fraker and Steven M Hahn},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2001},
  volume={7 2},
  pages={374-81}
}
Intraperitoneal photodynamic therapy (IP PDT) is an experimental cancer treatment in clinical development for the treatment of peritoneal carcinomatosis and sarcomatosis. A canine study of motexafin lutetium (Lu-Tex)-mediated IP PDT was performed to evaluate normal tissue toxicities of this treatment in the presence and absence of a bowel resection and to… CONTINUE READING